相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
Johanna G. H. van Nes et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Development of Sporadic Microsatellite Instability in Colorectal Tumors Involves Hypermethylation at Methylated-In-Tumor Loci in Adenoma
Michiel F. G. de Maat et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients
Ilse Van der Auwera et al.
BMC CANCER (2010)
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing
Yoshinao Ruike et al.
BMC GENOMICS (2010)
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
Isabella Castellano et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
Partha S. Ray et al.
CANCER RESEARCH (2010)
Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer
Lian Li et al.
HUMAN MOLECULAR GENETICS (2010)
Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
Marco Colleoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain et al.
LANCET ONCOLOGY (2010)
DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy
Oliver Hartmann et al.
CLINICAL CANCER RESEARCH (2009)
CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
Atsushi Tanemura et al.
CLINICAL CANCER RESEARCH (2009)
Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor-Negative Breast Cancer
Corey Speers et al.
CLINICAL CANCER RESEARCH (2009)
Epigenetics and cancer treatment
Lasse Sommer Kristensen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
Andre Albergaria et al.
BREAST CANCER RESEARCH (2009)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
Epigenetic biomarkers for human cancer: The time is now
Sonia Mulero-Navarro et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence
Michiel F. G. de Maat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epigenomics and breast cancer
Pang-Kuo Lo et al.
PHARMACOGENOMICS (2008)
Cell type-specific DNA methylation patterns in the human breast
Noga Bloushtain-Qimron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
Christina Yau et al.
BREAST CANCER RESEARCH (2008)
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors
Eiji Sunami et al.
BREAST CANCER RESEARCH (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma
Lorenzo Pasquali et al.
CANCER LETTERS (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Breast cancer: origins and evolution
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2007)
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group
Sabine Maier et al.
EUROPEAN JOURNAL OF CANCER (2007)
Tutorial in biostatistics: Competing risks and multi-state models
H. Putter et al.
STATISTICS IN MEDICINE (2007)
Assessment of methviation events durinq colorectal tumor progression by absolute quantitative analysis of methylated alleles
Michiel F. G. de Maat et al.
MOLECULAR CANCER RESEARCH (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Lisa K. Dunnwald et al.
BREAST CANCER RESEARCH (2007)
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
Weiwei Feng et al.
BREAST CANCER RESEARCH (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK
Daniel F. Hayes et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Synthesis of universal unmethylated control DNA by nested whole genome amplification with φ29 DNA polymerase
N Umetani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis
M Shinozaki et al.
CLINICAL CANCER RESEARCH (2005)
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
T Sorlie
EUROPEAN JOURNAL OF CANCER (2004)
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer
MJ Fackler et al.
CANCER RESEARCH (2004)
DNA methylation of RASSF1A, Hin-1, RAR-β, cyclin D2 and twist in in situ and invasive lobular breast carcinoma
MJ Fackler et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
